Zoetis (ZOET) Q4 Earnings Up 12% to $1.1B, Revenue Surpasses $2.4B

Zoetis (ZOET) reports Q4 2025 earnings of $1.1B, up 12% year-over-year, driven by strong demand for its animal health products and higher vaccine sales. Revenue reached $2.4B, exceeding the $2.35B median estimate. The company attributed the results to the launch of new vaccines and improved pricing in key markets. EPS for the quarter was $1.26, up from $1.12 in the same period last year. The stock closed at $78.45 on February 12, 2026, up 2.3% for the session.